歐洲基因檢測市場按檢測類型和國家分類 - 分析與預測（2024-2033）

預計2024年歐洲基因檢測市場價值將達71.3億美元。

預計到 2034 年，市場規模將達到 210.6 億美元，2024-2034 年預測期內的複合年成長率為 12.79%。由於技術的不斷改進，歐洲市場正在迅速擴張。基因定序技術的進步，尤其是次世代定序（NGS），使得基因檢測更加準確、有效率且經濟實惠。隨著醫療專業人員和公眾對基因檢測對於遺傳疾病的診斷和治療的益處的認知不斷提高，需求也隨之增加。此外，遺傳疾病和遺傳性癌症發生率的上升凸顯了早期診斷和個人化治療方案的必要性。產前檢測、新生兒篩檢、腫瘤學和精準醫療等基因檢測的應用不斷擴大，進一步推動了市場的成長。監管支持和協調的歐洲指導方針保證了基因檢測的品質和可靠性，促進了整個全部區域的市場擴張。

由於基因序列測定技術的發展、人們認知的不斷提高以及個人化醫療需求的不斷增加，歐洲基因檢測市場正在迅速成長。基因檢測對於診斷遺傳疾病、檢測遺傳疾病傾向以及促進罕見遺傳疾病、囊腫纖維化和遺傳性癌症的早期療育至關重要。

次世代定序（NGS）技術的廣泛應用大大提高了基因檢測的準確性、有效性和可負擔性，使患者和醫療保健專業人員更容易獲得基因檢測。政府支持新生兒篩檢和攜帶者檢測計劃的舉措、有利的法律規範和報銷政策進一步推動了市場擴張。

遺傳疾病和遺傳性癌症的發生率不斷上升，推動了對全面檢測解決方案的需求。此外，直接面對消費者（DTC）的基因檢測服務正變得越來越受歡迎，這種服務允許人們無需醫生處方箋即可獲得基因資訊。在生殖健康測試、腫瘤遺傳學和個人化醫療方面的大量投資正在進一步擴大市場範圍。

只要歐洲繼續優先考慮精準醫療和早期疾病檢測，基因檢測市場預計將穩定成長。預計技術進步、監管協調和公眾意識的提高將推動這一成長。

本報告研究了歐洲基因檢測市場，提供了市場概況以及基因檢測類型、國家和公司概況的趨勢。

目錄

執行摘要

第 1 章 基因檢測：產業展望

• 基因檢測現況
• 市場足跡與未來潛力
• 趨勢：當前和未來的影響評估
• 研發回顧
• 市場整體規模及滲透率
• 法律和監管框架
• 贖回情況
• 市場動態

第2章 區域

• 促進因素與限制因素
• 歐洲

第3章 市場競爭基準化分析與公司概況

• 競爭格局
  • 關鍵策略和發展
  • 企業市場占有率分析
• 公司簡介
  • Centogene AG
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd

第4章調查方法

Introduction to Europe Hereditary Genetic Testing Market

The Europe hereditary genetic testing market was valued at $7.13 billion in 2024 and is anticipated to reach $21.06 billion by 2034, witnessing a CAGR of 12.79% during the forecast period 2024-2034. The market in Europe is expanding rapidly due to continuous technological improvements. Genetic testing is now more accurate, efficient, and affordable thanks to advancements in genetic sequencing technologies, especially next-generation sequencing (NGS). Demand is being driven by growing awareness of the advantages of genetic testing for diagnosing and treating hereditary conditions among healthcare professionals and the public. Additionally, the need for early diagnosis and individualized treatment solutions is highlighted by the rising incidence of genetic disorders and hereditary cancers. The expanding applications of genetic testing, such as prenatal and newborn screening, oncology, and precision medicine, further bolster the market's growth. The quality and dependability of genetic tests are guaranteed by regulatory support and harmonized European guidelines, which promote market expansion throughout the region.

Market Introduction

The market for hereditary genetic testing in Europe is growing quickly due to developments in genetic sequencing technologies, rising awareness, and a growing need for individualized medical care. In order to diagnose inherited disorders, detect genetic disease predispositions, and facilitate early interventions for conditions like rare genetic disorders, cystic fibrosis, and hereditary cancers, hereditary genetic testing is essential.

The accuracy, effectiveness, and affordability of genetic tests have increased dramatically with the widespread use of next-generation sequencing (NGS) technologies, opening up access to them for patients and healthcare professionals alike. Further propelling market expansion are government initiatives supporting newborn screening and carrier testing programs, as well as advantageous regulatory frameworks and reimbursement policies.

The rising incidence of genetic disorders and hereditary cancers is driving demand for comprehensive testing solutions. Additionally growing in popularity are direct-to-consumer (DTC) genetic testing services, which give people access to genetic information without a doctor's prescription. The market's scope is being further expanded by significant investments in reproductive health testing, oncology genetics, and personalized medicine.

The market for hereditary genetic testing is expected to grow steadily as long as Europe prioritizes precision medicine and early disease detection. This growth will be aided by technological advancements, harmonized regulations, and rising public awareness.

Market Segmentation:

Segmentation 1: by Genetic Testing Type

• Oncology Genetic Testing
• Cardiology Genetic Testing
• Neurology Genetic Testing
• Newborn Screening
• Prenatal Screening (NIPT) and Preimplantation Testing
• Rare Disease Testing
• Direct-to-consumer (DTC) Testing

Segmentation 2: by Region

• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Netherlands
  • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe hereditary genetic testing market has been extensively segmented based on various categories, such as genetic testing type and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Partnerships, alliances, and collaborations accounted for the maximum number of key developments.

Competitive Strategy: The Europe hereditary genetic testing market has numerous established players with product portfolios. Key players in the Europe hereditary genetic testing market analyzed and profiled in the study involve established players offering products for hereditary genetic testing.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Centogene AG
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd

Table of Contents

Executive Summary

Scope and Definition

1 Hereditary Genetic Testing: Industry Outlook

• 1.1 Current State of Hereditary Genetic Testing
• 1.2 Market Footprint and Future Potential
• 1.3 Trends: Current and Future Impact Assessment
  • 1.3.1 Increasing Demand for Direct-to-consumer Testing
  • 1.3.2 Increasing Launch of Innovative Products and Regulatory Approvals in Genetic Testing Ecosystem
• 1.4 R&D Review
  • 1.4.1 Patent Filing Trend (by Year, Country)
• 1.5 Total Addressable Market and Penetration
• 1.6 Legal and Regulatory Framework
  • 1.6.1 Europe
    • 1.6.1.1 Germany
    • 1.6.1.2 France
    • 1.6.1.3 Italy
• 1.7 Reimbursement Scenario
• 1.8 Market Dynamics
  • 1.8.1 Market Drivers
    • 1.8.1.1 Rising Prevalence of Genetic Disorders along with Rare Diseases
    • 1.8.1.2 Increasing Inorganic Growth Activities in the Field of Hereditary Genetic Testing
    • 1.8.1.3 Increasing Number of Hereditary Genetic Tests
  • 1.8.2 Market Restraints
    • 1.8.2.1 High Cost Associated with Testing
    • 1.8.2.2 Shortage of Genetic Counselors
  • 1.8.3 Market Opportunities
    • 1.8.3.1 Expansion into Emerging Markets

2 Region

• 2.1 Drivers and Restraints
• 2.2 Europe
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 France
  • 2.2.5 Germany
  • 2.2.6 U.K.
  • 2.2.7 Spain
  • 2.2.8 Netherlands
  • 2.2.9 Rest-of-Europe

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Competitive Landscape
  • 3.1.1 Key Strategies and Development
    • 3.1.1.1 Mergers and Acquisitions
    • 3.1.1.2 Product Launches
    • 3.1.1.3 Synergistic Activities
    • 3.1.1.4 Business Expansion Activities and Others
  • 3.1.2 Company Share Analysis
• 3.2 Company Profiles
  • 3.2.1 Centogene AG
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products/Product Portfolio
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Key Personnel
    • 3.2.1.5 Analyst View
  • 3.2.2 Eurofins Scientific SE
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Key Personnel
    • 3.2.2.5 Analyst View
  • 3.2.3 F. Hoffmann-La Roche Ltd
    • 3.2.3.1 Top Products
    • 3.2.3.2 Top Competitors
    • 3.2.3.3 Key Personnel
    • 3.2.3.4 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast
• 4.3 Criteria for Company Profiling

List of Figures

• Figure 1: Hereditary Genetic Testing Market, by Region, $Billion, 2023, 2027, and 2033
• Figure 2: Europe Hereditary Genetic Testing Market (by Testing Type), $Billion, 2023 and 2033
• Figure 3: Key Events to Keep Track of in the Hereditary Genetic Testing Market
• Figure 4: Types of Hereditary Genetic Tests
• Figure 5: Hereditary Genetic Testing Market, Patent Analysis (by Year), January 2021-April 2024
• Figure 6: Hereditary Genetic Testing Market, Patent Analysis (by Country), January 2021-April 2024
• Figure 7: Europe Hereditary Genetic Testing Market Scenario, 2023
• Figure 8: Analysis of Market Navigating Factors, 2024-2033
• Figure 9: Rising Prevalence of Genetic Disorders
• Figure 10: Prevalence of a Few Rare Diseases
• Figure 11: Few Major Inorganic Growth Activities in the Hereditary Genetic Testing Market
• Figure 12: Number of Hereditary Genetic Tests Registered on Genetic Testing Registry, by Year
• Figure 13: Need for More Genetic Counselors
• Figure 14: Key Expansions in the Past Few Years
• Figure 15: France Hereditary Genetic Testing Market, $Billion, 2022-2033
• Figure 16: Germany Hereditary Genetic Testing Market, $Billion, 2022-2033
• Figure 17: U.K. Hereditary Genetic Testing Market, $Billion, 2022-2033
• Figure 18: Spain Hereditary Genetic Testing Market, $Billion, 2022-2033
• Figure 19: Netherlands Hereditary Genetic Testing Market, $Billion, 2022-2033
• Figure 20: Rest-of-Europe Hereditary Genetic Testing Market, $Billion, 2022-2033
• Figure 21: Number of Mergers and Acquisitions (by Company), January 2021-April 2024
• Figure 22: Number of Product Launches (by Company), January 2021-April 2024
• Figure 23: Synergistic Activities Share (by Company), January 2021-April 2024
• Figure 24: Business Expansion Activities Share (by Company), January 2021-April 2024
• Figure 25: Hereditary Genetic Testing Market, Company Revenue Share Analysis, $Billion, 2023
• Figure 26: Data Triangulation
• Figure 27: Top-Down and Bottom-Up Approach
• Figure 28: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Opportunities across Regions
• Table 3: Hereditary Genetic Testing Market, Product Launches and Regulatory Approvals
• Table 4: Regulatory Bodies Governing Hereditary Genetic Testing
• Table 5: Europe Hereditary Genetic Testing Market (by Genetic Testing Type), $Billion, 2022-2033